Replimune Group, Inc. (REPL)
7.04
-0.26
(-3.56%)
USD |
NASDAQ |
Jan 16, 16:00
7.18
+0.14
(+1.99%)
After-Hours: 20:00
Replimune Group Shareholders Equity (Annual): 415.84M for March 31, 2025
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Rapt Therapeutics, Inc. | 189.90M |
| Olema Pharmaceuticals, Inc. | 408.96M |
| CorMedix, Inc. | 84.66M |
| Verastem, Inc. | -28.89M |
| Anavex Life Sciences Corp. | 94.87M |